company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40486000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40486000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2802000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2802000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37684000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17096000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7962000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2044000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27102000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10582000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16974000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16970000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6388000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6388000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6388000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6388000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35423000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35423000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:31:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44753000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44753000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3091000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3091000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41662000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18040000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7317000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27219000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14443000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1197000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1200000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13243000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13243000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13243000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13243000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38965000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41737000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:09:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50881000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50881000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2809000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2809000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48072000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19911000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3695000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25468000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22604000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,777000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-777000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21827000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21827000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21827000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21827000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40362000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45697000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40400000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:20:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64567000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64567000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3370000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3370000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61197000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22094000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3382000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27338000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33859000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-657000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-657000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33202000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33202000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33202000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33202000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41209000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46601000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:14:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73293000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73293000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3901000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3901000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69392000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30547000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3279000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35688000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33704000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1097000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-125000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1222000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32482000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32482000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32482000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32482000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42028000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47241000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 18:57:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83536000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83536000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79674000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36384000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3764000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1862000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42010000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37664000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-627000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-818000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-191000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37473000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37473000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37473000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37473000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41499000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46798000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102530000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102530000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7744000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7744000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94786000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44356000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3959000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,10732000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59047000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35739000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35752000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5517000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30235000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2554000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27681000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27681000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53923000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58084000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:25:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,124231000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,124231000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12289000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12289000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111942000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57224000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2321000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,12970000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72515000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39427000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1481000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-240000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1721000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37706000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6593000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31113000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-3968000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27145000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27145000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56952000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60554000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56600000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:21:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,175515000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,175515000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32629000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32629000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,142886000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60924000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6920000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19742000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,87586000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,55300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7750000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1099000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8849000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46451000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12856000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33595000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-386000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33209000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33209000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57703000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60883000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:21:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,183703000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,183703000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25763000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25763000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157940000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61378000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7277000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,21907000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90562000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67378000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7651000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2281000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9932000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57446000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-108760000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,166206000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,34345000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,200551000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,200551000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56643000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.52
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60195000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.31
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.52
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,196237000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,196237000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27220000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27220000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,169017000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70528000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10747000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19555000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100830000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,68187000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7399000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,271000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7128000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61059000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17634000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43425000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43425000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43425000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58358000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61511000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:23:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,208252000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,208252000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25031000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25031000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,183221000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77506000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9250000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19399000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106155000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,77066000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3749000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7142000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-385000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11276000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65790000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23605000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42185000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42185000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42185000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58737000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61568000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58600000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:24:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,232160000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,232160000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24252000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24252000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,207908000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74970000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12814000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19564000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107348000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,100560000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6202000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-614000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6816000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,93744000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18335000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75409000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75409000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75409000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58217000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61519000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:24:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,235774000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,235774000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25643000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25643000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,210131000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81299000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13809000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,20524000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,115632000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,94499000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6173000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-969000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7142000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,87357000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32064000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55293000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55293000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55293000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58298000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61569000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,246919000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,246919000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30924000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30924000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,215995000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,106363000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,145109000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,31182000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,282654000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66659000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-10076000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,123000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9953000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-76612000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17027000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93639000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93639000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-989000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-92650000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58526000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.58
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58526000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.58
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58600000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:21:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.58
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,291230000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,291230000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30692000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30692000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,260538000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,100556000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20090000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,32795000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,32806000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,186247000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,74291000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-11429000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,74000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11355000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62936000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19350000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43586000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43586000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-73000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43659000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59519000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.73
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62378000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59800000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:18:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.73
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,306584000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,306584000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26994000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26994000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279590000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,93501000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97423000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,30630000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,221554000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58036000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14530000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6483000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8047000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49989000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24221000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25768000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25768000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25766000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60305000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62680000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59900000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:47:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,328142000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,328142000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28808000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28808000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,299334000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,105694000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25185000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,31977000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,6559000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,169415000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,129919000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-16678000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2003000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14675000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,115244000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33633000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,81611000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,81611000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,81612000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59746000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62614000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.4
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59600000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,309303000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,309303000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28298000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28298000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,281005000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,112388000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27181000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,24677000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,164246000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,116759000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-16245000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2245000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,102759000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32059000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,70700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,70700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,70700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60803000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62964000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.12
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60900000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:12:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,333747000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,333747000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21813000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21813000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,311934000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,107132000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27833000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,23668000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,158633000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,153301000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16815000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15812000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1914000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34541000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,118760000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30647000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88113000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,88113000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,88114000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61190000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.44
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63090000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.4
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61200000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.44
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,340872000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,340872000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28385000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28385000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,312487000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,104044000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50784000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,26127000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,180955000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,131532000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12650000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-977000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13627000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,117905000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29945000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,87960000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,87960000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,87960000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61435000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63154000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.39
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:11:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,340881000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,340881000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24030000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24030000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,316851000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,125555000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29455000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,23690000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,31523000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,210223000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,106628000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12210000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2091000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10119000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,96509000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13748000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,82761000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,82761000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,82761000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61232000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63036000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,336010000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,336010000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23439000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23439000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,312571000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,128765000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40002000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,22642000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,191409000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,121162000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12192000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-819000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13011000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,108151000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32339000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75812000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75812000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75812000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61142000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62616000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.21
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61100000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:09:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,381161000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,381161000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23980000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23980000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,357181000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,122618000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39091000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,26737000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,188446000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,168735000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12121000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12121000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,156614000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42112000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,114502000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,114502000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,114502000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60499000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62043000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.85
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60600000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:23:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,374181000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,374181000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24311000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24311000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,349870000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,124368000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62796000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,26453000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,213617000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,136253000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,638000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18498000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-749000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19885000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,116368000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26437000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-103000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,89828000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,89828000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,89828000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60437000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61795000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.45
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 17:07:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,396621000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,396621000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33656000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33656000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,362965000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,127141000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44158000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,26162000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,197461000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,165504000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19131000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4940000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14191000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,151313000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34348000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-276000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,116689000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,116689000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,116689000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.94
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61870000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.9
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.94
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,376053000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,376053000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25065000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25065000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,350988000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,144255000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44928000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25665000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,214848000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,136140000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18844000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1464000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20308000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,115832000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29160000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-161000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86511000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86511000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,86511000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59880000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.44
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61178000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60100000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:11:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.44
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,394386000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,394386000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28672000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28672000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,365714000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,132328000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42157000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,26186000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200671000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,165043000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18294000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5427000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23721000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,141322000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35515000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-203000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,105604000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,105604000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,105604000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60100000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.76
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61463000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.72
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:06:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.76
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,411855000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,411855000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31203000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31203000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,380652000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,124523000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,122362000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,47313000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,294198000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,86454000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19192000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2224000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21416000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65038000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1239000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-273000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63526000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63526000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63526000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60108000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.06
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61436000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.03
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59900000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 17:04:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.06
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,436399000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,436399000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25248000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25248000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,411151000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,143050000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,73995000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,52901000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,269946000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,141205000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-21426000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-854000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22280000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,118925000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-113654000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-372000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,232207000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,232207000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,232207000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60018000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.87
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61317000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.8
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.87
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,444613000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,444613000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33919000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33919000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,410694000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,207213000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62667000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,53007000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,322887000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87807000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-20605000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1728000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22333000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65474000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19146000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-337000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45991000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45991000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45991000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59928000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61178000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.75
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,500479000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,500479000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34714000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34714000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,465765000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,158579000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56132000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,54959000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,42896000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,312566000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,153199000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1425000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19646000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2697000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23768000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,129431000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-586000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92345000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,92321000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,92321000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60177000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.53
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61438000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:11:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.53
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469373000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469373000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26574000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26574000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,442799000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,155873000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51160000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,46989000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,254022000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,188777000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18920000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-756000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19676000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,169101000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19300000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-437000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,149364000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,149316000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,149316000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60476000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.47
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61857000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.41
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60500000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:09:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.47
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,476457000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,476457000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26337000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26337000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,450120000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,161865000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56657000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,46543000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,265065000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,185055000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-17904000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1694000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19598000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,165457000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5216000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-843000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,159398000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,159470000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,159470000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59976000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.68
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61221000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.64
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60000000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.68
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,508186000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,508186000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33506000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33506000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,474680000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167947000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,116105000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,56885000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,340937000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,133743000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-17922000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-611000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18533000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,115210000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29116000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-893000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,85201000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,85201000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,85201000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57206000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58081000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57200000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 17:07:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,534133000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,534133000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27676000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27676000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,506457000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,176014000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64584000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,61576000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,302174000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,204283000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18234000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1933000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20167000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,184116000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-78700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-868000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,261948000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,261898000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,261898000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56707000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.62
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57427000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.56
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56700000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:11:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.62
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,537702000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,537702000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31400000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31400000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,506302000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,178706000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,131630000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,62863000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,373199000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,133103000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-17861000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1033000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18894000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,114209000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10900000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1030000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102279000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,102276000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,102276000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56674000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57438000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.78
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56800000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:09:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,581740000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,581740000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35348000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35348000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,546392000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,214275000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97382000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,173490000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,485147000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61245000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18244000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2234000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20478000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40767000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-34470000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1298000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73939000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73992000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73992000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56749000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.31
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57550000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56800000.0
Jazz Pharmaceuticals PLC,JAZZ,,0001232524,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.31
